paper-with-me

Papers

Contextual Constrained Learning for Dose-Finding Clinical Trials

2020-01-08 · Hyun-Suk Lee, Cong Shen, James Jordon, Mihaela van der Schaar

Clinical trials in the medical domain are constrained by budgets. The number of patients that can be recruited is therefore limited. When a patient population is heterogeneous, this creates difficulties in learning subgroup specific responses to a particular drug and especially for a variety of dosages. In addition, patient recruitment can be difficult by the fact that clinical trials do not aim to provide a benefit to any given patient in the trial. In this paper, we propose C3T-Budget, a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. The algorithm aims to maximize drug efficacy within the clinical trial while also learning about the drug being tested. C3T-Budget recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group, such as the population distribution, estimated expected efficacy, and estimation credibility. In addition, the algorithm aims to avoid unsafe dosages. These characteristics are further illustrated in a simulated clinical trial study, which corroborates the theoretical analysis and demonstrates an efficient budget usage as well as a balanced learning-treatment trade-off.

📄 PDF Abstract BibTeX arXiv:2001.02463

Code (1)

https://bitbucket.org/mvdschaar/mlforhealthlabpub 공식 구현 tf

Similar Papers 제목 키워드 기반

On Multi-Armed Bandit Designs for Dose-Finding Clinical Trials

2019-03-17 · Maryam Aziz, Emilie Kaufmann, Marie-Karelle Riviere

We study the problem of finding the optimal dosage in early stage clinical trials through the multi-armed bandit lens. We advocate the use of the Thompson Sampling principle, a flexible algorithm that can accommodate dif…

Thompson Sampling

Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraints

2020-06-09 · ICML 2020 1 · Cong Shen, Zhiyang Wang, Sofia S. Villar, Mihaela van der Schaar

Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds (or combination of them) becomes more complex. Despite this, most commonly used methods in pract…

Dose-finding design based on level set estimation in phase I cancer clinical trials

2025-04-12 · Keiichiro Seno, Kota Matsui, Shogo Iwazaki, Yu Inatsu 외

The primary objective of phase I cancer clinical trials is to evaluate the safety of a new experimental treatment and to find the maximum tolerated dose (MTD). We show that the MTD estimation problem can be regarded as a…

SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups

2021-01-26 · Hyun-Suk Lee, Cong Shen, William Zame, Jang-Won Lee 외

Phase I clinical trials are designed to test the safety (non-toxicity) of drugs and find the maximum tolerated dose (MTD). This task becomes significantly more challenging when multiple-drug dose-combinations (DC) are in…

Shared Keyboard: An improved Bayesian design for phase I clinical trials via Beta kernel process

2026-05-24 · Jiangyan Zhao, Xian Shi, Jin Xu arxiv

Model-assisted interval designs such as the Keyboard design are transparent and easy to implement in phase I oncology trials. However, interim decisions based solely on data from the current dose may overlook informative…